Sigma-Aldrich Corp (NASDAQ:SIAL)

part of the mattchenzo 50, picked from the s&p500 on fundamentals, almost sure to outperform!

When a stock gets positive press, it usually does pretty well. On 4/24/08, the Street.com named SIAL one of 5 top midcaps. The company gets the positive buzz for good reason. The company grew 14.9% in Q1 FY08 versus Q1 FY07. Net income increased by 12.8%. In addition, the management has raised their earning forecast for full FY08 by $0.05 per share to $2.57 to $2.67, up 9.8% and 14.1% over FY07. The company is highly efficient, is financially solvent, has improved income and has shown outstanding growth.

Undervalued, target is $66. Has proven products used worldwide as reflected in net income. This stock is holding up well via relative strength over its 3, 6, and 12 month periods.

produces specialty chemicals and kits used in scientific and genomic research, drug development and the diagnosis of disease. It produces more than 100,000 products, operates in three dozen countries and has more than 60,000 government and private-sector customers.

The St. Louis company focuses on finding growth opportunities in the biotech industry. It recently made a strategic investment in a life-sciences venture fund, Prolog Ventures.

Its research biotech unit accounted for 15% of overall sales in 2007, a year in which Sigma-Aldrich topped $2 billion in sales for the first time. Management vowed to continue its annual trend of delivering at least 10% growth in sales and earnings in 2008.

The company sees growth potential in booming Asia-Pacific economies such as India and China, and it's pursuing clients among small- and mid-sized biotech companies, the St. Louis Post-Dispatch reported. Growth in the U.S. market is hobbled by a stagnant federal research budget as well as the struggles of its big pharmaceutical clients.

Nano tube technology

Steady, rapid growth all year. A+

Sigma Aldrich is moving into the China and India markets very aggressively.

Best stock ideas 2008

ratocyte@ 53

This sector is just getting stronger and stronger

genetic research will be as all consuming to our children's generation as communications have been to ours. humans are almost as compelled to look into themselves and communicate as they are to eat and mate.

This company is money in the bank..Great earning numbers decent dividen..With alot of the product being used over seas and the weak dollar it is only looking better for SIAL...This will be at 65 by the second Q.

A solid company with a good history. The demand for their existing products will only go up. These guys feed Science and Tech, and I don't think they are overvalued at all in today's world.

materials will continue to be needed & profitable.

Medical/nano-tech play with a long-term view

As long as there is something that needs chemical testing or pharmaceutical development, I believe that this stock continue grow.

Sigma Aldrich is the best at providing information and specialty chemicals to the continuously growing market: chemical- and biotech-related research.

Looks like a long term winner

ride the biotech wave by selling picks and shovels